Knee Bursitis Global Market Report 2024

Description

Knee bursitis occurs when one or more of the small, fluid-filled sacs near the knee joint become inflamed. These sacs, called bursae, cushion and reduce friction between tissues such as bones, tendons, and muscles. Inflammation of these bursae leads to symptoms such as pain, swelling, and limited movement in the knee.

Diagnosis of knee bursitis typically involves imaging tests such as ultrasound or MRI scans. These tests help visualize inflammation and fluid buildup in the bursae surrounding the knee joint. Treatment options include medication and, in some cases, surgery. These treatments are utilized by hospitals, clinics, diagnostic centers, research institutions, academic establishments, and others.

The knee bursitis research report is one of a series of new reports from The Business Research Company that provides knee bursitis market statistics, including the knee bursitis industry's global market size, regional shares, competitors with a knee bursitis market share, detailed knee bursitis market segments, market trends and opportunities, and any further data you may need to thrive in the knee bursitis industry. This knee bursitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The knee bursitis market size has grown strongly in recent years. It will grow from $2.48 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. During the historic period, growth can be attributed to factors such as an aging population, increased engagement in sports and physical activities, enhanced diagnostic techniques, improved healthcare access, and educational initiatives targeting healthcare professionals and patients.

The knee bursitis market size is expected to see strong growth in the next few years. It will grow to $3.54 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth is anticipated due to heightened awareness initiatives focused on prevention and management, augmented disposable incomes, escalating healthcare expenditures, and greater awareness and diagnosis of knee bursitis. Key trends in the forecast period encompass advancements in diagnostic methods, the emergence of innovative therapies, progress in research and development endeavors, as well as the adoption of telemedicine and remote monitoring technologies.

The growing prevalence of bone-related diseases, such as osteoporosis, arthritis, and bone cancer, is expected to drive the expansion of the knee bursitis market in the future. These diseases affect the skeletal system's structure, strength, and functionality, and are increasingly prevalent due to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Conditions such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa, resulting in pain, swelling, and reduced joint function. For example, Healthy Bones Australia projected in September 2022 that Australia would have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia in 2022, highlighting the significant impact of poor bone health on knee-related conditions. Therefore, the rising prevalence of bone-related diseases is a key driver of growth in the knee bursitis market.

The anticipated growth of the knee bursitis market is expected to be driven by the increasing diabetic population in the coming years. Diabetes, a chronic condition characterized by the body's inability to regulate blood sugar levels effectively, results from insufficient insulin production or ineffective insulin use. Factors contributing to the rise in diabetes cases include sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetic individuals are at higher risk of developing knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. For instance, a July 2021 report by the International Diabetes Federation projected a substantial increase in the global diabetic population, estimating 643 million people living with diabetes by 2030 and 783 million by 2045. Therefore, the expanding diabetic population is a key driver behind the expected growth of the knee bursitis market.

The growth of the knee bursitis market is expected to be driven by the increasing geriatric population in the years ahead. The geriatric population, typically defined as individuals aged 65 years and older, faces specific health challenges associated with aging. Advances in healthcare have contributed to longer life expectancies globally while declining birth rates in many regions have further contributed to the aging demographic trend. Among the health issues commonly experienced by older adults is knee bursitis, which results from wear and tear on the joints, leading to inflammation of the bursae sacs surrounding the knee joint. For example, the World Health Organization projected in October 2022 that the global population aged 60 years and over will grow significantly, from 1 billion in 2020 to 1.4 billion by 2030, reaching 2.1 billion by 2050. Moreover, the number of individuals aged 80 years and older is expected to triple, reaching 426 million by 2050. This demographic shift underscores the increasing prevalence of knee bursitis among older adults, driven by age-related joint issues. Therefore, the expanding geriatric population is a pivotal factor propelling the growth of the knee bursitis market as healthcare systems adapt to meet the needs of an aging population facing joint-related challenges.

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the knee bursitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The knee bursitis market consists of revenues earned by entities by providing services such as medical consultation, medication management, surgical intervention, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee bursitis market also includes sales of knee braces and supports, cold packs and heat wraps, anti-inflammatory medications, and corticosteroid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Knee Bursitis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on knee bursitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for knee bursitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The knee bursitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Diagnosis: Imaging Test; Other Diagnosis Tests
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Bayer AG; Novartis AG; Roche Holding AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18903

1. Executive Summary

2. Knee Bursitis Market Characteristics

3. Knee Bursitis Market Trends And Strategies

4. Knee Bursitis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Knee Bursitis Market Size and Growth

5.1. Global Knee Bursitis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Knee Bursitis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Knee Bursitis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Knee Bursitis Market Segmentation

6.1. Global Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Imaging Test
Other Diagnosis Tests
6.2. Global Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Therapy
Surgery
Other Treatments
6.3. Global Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Research Centers
Academic Institutes
Other End Users

7. Knee Bursitis Market Regional And Country Analysis

7.1. Global Knee Bursitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Knee Bursitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Knee Bursitis Market

8.1. Asia-Pacific Knee Bursitis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Knee Bursitis Market

9.1. China Knee Bursitis Market Overview
9.2. China Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Knee Bursitis Market

10.1. India Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Knee Bursitis Market

11.1. Japan Knee Bursitis Market Overview
11.2. Japan Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Knee Bursitis Market

12.1. Australia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Knee Bursitis Market

13.1. Indonesia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Knee Bursitis Market

14.1. South Korea Knee Bursitis Market Overview
14.2. South Korea Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Knee Bursitis Market

15.1. Western Europe Knee Bursitis Market Overview
15.2. Western Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Knee Bursitis Market

16.1. UK Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Knee Bursitis Market

17.1. Germany Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Knee Bursitis Market

18.1. France Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Knee Bursitis Market

19.1. Italy Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Knee Bursitis Market

20.1. Spain Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Knee Bursitis Market

21.1. Eastern Europe Knee Bursitis Market Overview
21.2. Eastern Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Knee Bursitis Market

22.1. Russia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Knee Bursitis Market

23.1. North America Knee Bursitis Market Overview
23.2. North America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Knee Bursitis Market

24.1. USA Knee Bursitis Market Overview
24.2. USA Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Knee Bursitis Market

25.1. Canada Knee Bursitis Market Overview
25.2. Canada Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Knee Bursitis Market

26.1. South America Knee Bursitis Market Overview
26.2. South America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Knee Bursitis Market

27.1. Brazil Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Knee Bursitis Market

28.1. Middle East Knee Bursitis Market Overview
28.2. Middle East Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Knee Bursitis Market

29.1. Africa Knee Bursitis Market Overview
29.2. Africa Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Knee Bursitis Market Competitive Landscape And Company Profiles

30.1. Knee Bursitis Market Competitive Landscape
30.2. Knee Bursitis Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Roche Holding AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Knee Bursitis Market Other Major And Innovative Companies

31.1. Medtronic plc
31.2. Eli Lilly and Company
31.3. Amgen Inc
31.4. Gilead Sciences Inc.
31.5. Stryker Corporation
31.6. Regeneron Pharmaceuticals Inc.
31.7. Biogen Inc.
31.8. Vertex Pharmaceuticals Incorporated
31.9. Zimmer Biomet Holdings Inc.
31.10. DePuy Synthes Inc.
31.11. Arthrex Inc.
31.12. Globus Medical Inc.
31.13. Bioventus LLC
31.14. Exactech Inc.
31.15. Genentech Inc.

32. Global Knee Bursitis Market Competitive Benchmarking

33. Global Knee Bursitis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Knee Bursitis Market

35. Knee Bursitis Market Future Outlook and Potential Analysis

35.1 Knee Bursitis Market In 2028 - Countries Offering Most New Opportunities
35.2 Knee Bursitis Market In 2028 - Segments Offering Most New Opportunities
35.3 Knee Bursitis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer